1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Industry in European Union Market Research & Statistics

Cancer Industry in European Union Market Research & Statistics

Customer Support

Talk to Sam

+1 646 893 5945

All regions

About 200 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Cancer Statistics in EU - Forecast

  • April 2020
  • 5 pages
  • Cancer
  • Healthcare
  • Pathology
  • European Union
View report >

Cobalt Industry in EU

  • March 2020
  • 159 pages
  • Cancer
  • Occupational Health
  • European Union
  • Market Size
  • Supply
View report >

Cancer Statistics in Europe - Forecast

  • January 2020
  • 5 pages
  • Cancer
  • Pathology
  • Europe
  • European Union
  • Social Conditions
View report >

Lung Cancer Statistics - Forecast

  • January 2020
  • 1 pages
  • Cancer
  • Lung Cancer
  • Pathology
  • European Union
  • South Korea
View report >

Cancer Statistics in EU

  • January 2020
  • 7 pages
  • Cancer
  • Pathology
  • European Union
View report >

Hospital Industry in Europe - Forecast

  • January 2020
  • 7 pages
  • Cancer
  • Health Services
  • Hospital
  • Europe
  • European Union
View report >

Global Therapy Market and Oncology Market

  • January 2020
  • 108 pages
  • Cancer
  • Oncology
  • Therapy
  • European Union
  • OECD
View report >

Cancer Statistics in EU

  • January 2020
  • 9 pages
  • Cancer
  • Pathology
  • Europe
  • European Union
  • Demographic
View report >

Breast Cancer Statistics

  • December 2019
  • 11 pages
  • Breast Cancer
  • Cancer
  • Pathology
  • European Union
  • Demographic
View report >

Cancer Statistics in EU

  • November 2019
  • 12 pages
  • Cancer
  • Health Services
  • Pathology
  • European Union
  • Demographic

Search in Cancer Industry (About 200 reports)
Parent industry: Pathology
Related industries: Chronic Disease, Mental Health

About 100 reports

Purchase Reports From Reputable Market Research Publishers

Stivarga

  • $ 10000
  • September 2019
  • 30 pages

Drug Overview Stivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Cancer
  • Colorectal Cancer
  • Hepatitis
  • Pathology
  • European Union

Nexavar $ 10000 September 2019

Lenvima $ 10000 September 2019

Tecentriq $ 10000 September 2019

Opdivo $ 10000 September 2019

Cyramza $ 10000 September 2019

Imfinzi $ 10000 September 2019

Keytruda $ 10000 September 2019

Cabometyx $ 10000 September 2019

Votrient $ 10000 March 2019


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on